Pfizer's former R&D chief Dolsten pulls out of Novo Nordisk board race
Mikael Dolsten, Pfizer's former research and development chief, has withdrawn his candidacy for Novo Nordisk's board, citing personal reasons, the Danish drugmaker said on Thursday.
November 13, 2025
Key takeaways from a report into the deadly plane crash at LaGuardia Airport
Suncorp buys $1.7 billion reinsurance cover, sees FY26 premium growth of 3%
Trump says Navy Secretary Phelan was fired over shipbuilding conflicts
Las Vegas Raiders select Fernando Mendoza with the first overall pick in 2026 NFL draft
Jets start busy NFL draft with Texas Tech edge rusher David Bailey at No. 2 overall
Rangers call up 30-year-old pitcher seeking MLB debut after putting reliever Garcia on IL